ES2166481T3 - Benzoilguanidinas sustituidas en posicion orto. - Google Patents

Benzoilguanidinas sustituidas en posicion orto.

Info

Publication number
ES2166481T3
ES2166481T3 ES97102607T ES97102607T ES2166481T3 ES 2166481 T3 ES2166481 T3 ES 2166481T3 ES 97102607 T ES97102607 T ES 97102607T ES 97102607 T ES97102607 T ES 97102607T ES 2166481 T3 ES2166481 T3 ES 2166481T3
Authority
ES
Spain
Prior art keywords
replaced
indicated
benzoilguanidinas
ischemically
appearance
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES97102607T
Other languages
English (en)
Inventor
Udo Dr Albus
Joachim Dr Brendel
Heinz-Werner Dr Kleemann
Hans Jochen Dr Lang
Wolfgang Dr Scholz
Jan-Robert Dr Schwark
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG filed Critical Hoechst AG
Application granted granted Critical
Publication of ES2166481T3 publication Critical patent/ES2166481T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/20—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups containing any of the groups, X being a hetero atom, Y being any atom, e.g. acylguanidines
    • C07C279/22—Y being a hydrogen or a carbon atom, e.g. benzoylguanidines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Obesity (AREA)
  • Neurology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Biomedical Technology (AREA)
  • Surgery (AREA)
  • Neurosurgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

BENZOIL-GUANIDINAS SUSTITUIDAS EN POSICION ORTO DE FORMULA I EN LA QUE DE R(1) A R(4) TIENEN LOS SIGNIFICADOS INDICADOS EN LAS REIVINDICACIONES, SE UTILIZAN COMO MEDICAMENTOS ANTIARRITMICOS CON COMPONENTES CARDIOPROTECTORES PARA LA PREVENCION Y TRATAMIENTO DEL INFARTO, ASI COMO PARA EL TRATAMIENTO DE LA ANGINA DE PECHO. TAMBIEN INHIBEN DE MANERA PREVENTIVA LOS PROCESOS PATOFISIOLOGICOS EN LA APARICION DE LESIONES INDUCIDAS ISQUEMICAMENTE, EN PARTICULAR EN LA APARICION DE ARRITMIAS CARDIACAS INDUCIDAS ISQUEMICAMENTE.
ES97102607T 1996-03-04 1997-02-19 Benzoilguanidinas sustituidas en posicion orto. Expired - Lifetime ES2166481T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19608161A DE19608161A1 (de) 1996-03-04 1996-03-04 Ortho-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament

Publications (1)

Publication Number Publication Date
ES2166481T3 true ES2166481T3 (es) 2002-04-16

Family

ID=7787087

Family Applications (1)

Application Number Title Priority Date Filing Date
ES97102607T Expired - Lifetime ES2166481T3 (es) 1996-03-04 1997-02-19 Benzoilguanidinas sustituidas en posicion orto.

Country Status (30)

Country Link
US (1) US6262123B1 (es)
EP (1) EP0794172B1 (es)
JP (1) JP4039586B2 (es)
KR (1) KR970065511A (es)
CN (1) CN1071318C (es)
AR (1) AR006051A1 (es)
AT (1) ATE207462T1 (es)
AU (1) AU707619B2 (es)
BR (1) BR9701159A (es)
CA (1) CA2198980A1 (es)
CZ (1) CZ293144B6 (es)
DE (2) DE19608161A1 (es)
DK (1) DK0794172T3 (es)
ES (1) ES2166481T3 (es)
HR (1) HRP970125B1 (es)
HU (1) HUP9700542A3 (es)
ID (1) ID16106A (es)
IL (1) IL120358A (es)
MX (1) MX9701619A (es)
MY (1) MY116861A (es)
NO (1) NO308793B1 (es)
NZ (1) NZ314325A (es)
PL (1) PL185751B1 (es)
PT (1) PT794172E (es)
RU (1) RU2212400C2 (es)
SI (1) SI0794172T1 (es)
SK (1) SK283934B6 (es)
TR (1) TR199700131A2 (es)
TW (1) TW440558B (es)
ZA (1) ZA971815B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10001879A1 (de) * 2000-01-19 2001-07-19 Aventis Pharma Gmbh Substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
CN100371328C (zh) * 2006-01-19 2008-02-27 中国药科大学 取代苯甲酰基胍衍生物、其制备方法及其医药用途

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ284456B6 (cs) * 1992-02-15 1998-12-16 Hoechst Aktiengesellschaft Aminosubstituované benzoylguanidiny, způsob jejich přípravy, jejich použití jako léčiv a léčivo, které je obsahuje
TW250477B (es) 1992-12-15 1995-07-01 Hoechst Ag
ATE157351T1 (de) 1993-02-20 1997-09-15 Hoechst Ag Substituierte benzoylguanidine, verfahren zu ihrer herstellung, ihre verwendung als medikament, als inhibitoren des zellulären na+/h+-austauschs oder als diagnostikum sowie sie enthaltendes medikament
DE4318756A1 (de) 1993-06-05 1994-12-08 Hoechst Ag Substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE4328869A1 (de) * 1993-08-27 1995-03-02 Hoechst Ag Ortho-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE4404183A1 (de) * 1994-02-10 1995-08-17 Merck Patent Gmbh 4-Amino-1-piperidylbenzoylguanidine
DE4417004A1 (de) 1994-05-13 1995-11-16 Hoechst Ag Perfluoralkyl-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE4421495A1 (de) * 1994-06-20 1995-12-21 Merck Patent Gmbh Heterocyclyloxy-benzoylguanidine
DE4422685A1 (de) * 1994-06-29 1996-01-04 Hoechst Ag Ortho-amino-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE4430213A1 (de) * 1994-08-28 1996-02-29 Merck Patent Gmbh Arylbenzoylguanidine
DE4430861A1 (de) * 1994-08-31 1996-03-07 Merck Patent Gmbh Heterocyclyl-benzoylguanidine
DE19517848A1 (de) * 1995-05-16 1996-11-21 Merck Patent Gmbh Fluorhaltige Benzoylguanidine
DE19531138A1 (de) * 1995-08-24 1997-02-27 Merck Patent Gmbh Alkenyl-benzoylguanidin-Derivate
DE19624178A1 (de) * 1996-06-18 1998-01-08 Hoechst Ag Ortho-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament

Also Published As

Publication number Publication date
TW440558B (en) 2001-06-16
BR9701159A (pt) 1998-12-15
AU707619B2 (en) 1999-07-15
HUP9700542A3 (en) 1998-01-28
ID16106A (id) 1997-09-04
EP0794172B1 (de) 2001-10-24
HRP970125A2 (en) 1998-04-30
NO970963D0 (no) 1997-03-03
ATE207462T1 (de) 2001-11-15
CZ293144B6 (cs) 2004-02-18
JP4039586B2 (ja) 2008-01-30
SI0794172T1 (en) 2002-10-31
ZA971815B (en) 1997-09-04
PT794172E (pt) 2002-02-28
CN1071318C (zh) 2001-09-19
SK27697A3 (en) 1997-11-05
TR199700131A2 (tr) 1997-09-21
AR006051A1 (es) 1999-07-21
DK0794172T3 (da) 2002-02-11
SK283934B6 (sk) 2004-05-04
CN1160042A (zh) 1997-09-24
HU9700542D0 (en) 1997-04-28
CZ65497A3 (cs) 1998-05-13
HUP9700542A1 (en) 1997-12-29
NO970963L (no) 1997-09-05
PL318415A1 (en) 1997-09-15
NZ314325A (en) 1998-02-26
DE19608161A1 (de) 1997-09-11
MY116861A (en) 2004-04-30
KR970065511A (ko) 1997-10-13
HRP970125B1 (en) 2002-06-30
IL120358A0 (en) 1997-07-13
MX9701619A (es) 1998-04-30
US6262123B1 (en) 2001-07-17
PL185751B1 (pl) 2003-07-31
NO308793B1 (no) 2000-10-30
AU1499797A (en) 1997-09-11
CA2198980A1 (en) 1997-09-04
JPH107644A (ja) 1998-01-13
DE59705019D1 (de) 2001-11-29
EP0794172A1 (de) 1997-09-10
RU2212400C2 (ru) 2003-09-20
IL120358A (en) 2002-04-21

Similar Documents

Publication Publication Date Title
ES2135083T3 (es) Trifeniletilenos para la prevencion y el tratamiento de la osteoporosis.
ES2040234T3 (es) Derivados del tetrahidronaftaleno y medicamentos que los contienen.
GT199900067A (es) Nuevas 4-fenilpiperidinas para el tratamiento dedermatosis prurìtica.
ES2148503T3 (es) Derivados de 3-aril-4-hidroxi-delta3-dihidrotiofenona.
AR031430A1 (es) Compuestos de bisarilo orto, meta-sustituidos, procedimientos para su preparacion, su utilizacion como medicamento como tambien los preparados farmaceuticos que los contienen
ES2127850T3 (es) Sulfonilaminopirimidinas, su obtencion y utilizacion como medicamentos.
ES2179351T3 (es) Amidas acidas de piridil alqueno y piridil alquino como citoestaticos e inmunosupresores.
ES2194179T3 (es) Derivados heterociclicos como agentes antidiabeticos y antiobesidad.
AR004253A1 (es) Sulfonimidoamidas sustituidas, procedimiento para su preparacion, su utilizacion como medicamento o agente de diagnostico asi como medicamento quelas contiene.
AR020019A1 (es) Composicion farmaceutica para la prevencion o el tratamiento de cancer de mama
LV10924A (lv) Sintetiskie katalitiskie brivo radikalu akceptori kurus izmanto ka antioksidantus slimibu profilaksei un arstesanai
AR005703A1 (es) Oxazolidinonas sustituidas, procedimiento para su preparacion, uso de las mismas para preparar medicamentos y medicamentos que las contienen
ES2093694T3 (es) Nuevos derivados de dihidro-isoquinoleina.
ES2161697T3 (es) Peptidos agonistas de amilina y usos de los mismos.
ES2058185T3 (es) Derivados de camptotecina y procedimiento para su preparacion.
CR6592A (es) Compuestos para el tratamiento de la isquemia
ES2156107T3 (es) Un fgf-4 no glicosilado y composiciones que lo contienen.
ES2112453T3 (es) Benzoilguanidinas sustituidas, procedimiento para su preparacion, su empleo como medicamento o agente de diagnostico, asi como medicamento que las contiene.
MX9204390A (es) Bastidor para gabinete de mando.
ES2154002T3 (es) 2-naftoilguanidinas sustituidas, procedimiento para su preparacion, su utilizacion como medicamento o agente de diagnostico, asi como medicamento que las contiene.
ES2135722T3 (es) 1,5-benzodiacepinas 5-heterociclicas moduladoras de la cck o de la gastrina.
ES2116612T3 (es) Nuevas bis-naftalimidas para el tratamiento del cancer.
ES2047317T3 (es) Placas de apoyo para railes.
AR021463A1 (es) Antibiotico de piridona con perfil de seguridad mejorado
GT199500039AA (es) Compuestos ariltios

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 794172

Country of ref document: ES